|
Dr. Reddy's Laboratories Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
95970.71 Cr.
|
P/BV
|
3.12
|
Book Value (Rs.)
|
368.50
|
|
52 Week High/Low (Rs.)
|
1421/1020
|
FV/ML
|
1/1
|
P/E(X)
|
17.21
|
|
Bookclosure
|
28/10/2024
|
EPS (Rs.)
|
66.84
|
Div Yield (%)
|
0.70
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 27916.40 | 24587.90 | 21439.10 | 18972.20 | 17460.00 |
| Other Operating Revenues | 94.70 | 81.80 | 106.10 | 75.30 | 57.00 |
| Total Operating Revenues | 28011.10 | 24669.70 | 21545.20 | 19047.50 | 17517.00 |
| | | | | | |
| Other Income | 894.30 | 1055.50 | 484.40 | 291.40 | 620.60 |
| Total Revenue | 28905.40 | 25725.20 | 22029.60 | 19338.90 | 18137.60 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 4490.10 | 4219.80 | 4312.40 | 4295.80 | 2984.80 |
| Purchase Of Stock-In Trade | 4399.10 | 3367.00 | 3483.70 | 2573.60 | 2545.90 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -680.50 | 70.90 | -353.90 | -790.50 | 23.70 |
| Employee Benefit Expenses | 5030.10 | 4646.60 | 3885.80 | 3629.90 | 3380.20 |
| Finance Costs | 171.10 | 142.80 | 95.80 | 97.00 | 98.30 |
| Provisions And Contingencies | 0.30 | 69.90 | 930.40 | 676.80 | 1676.70 |
| Depreciation And Amortisation Expenses | 1470.00 | 1250.20 | 1165.20 | 1228.80 | 1163.10 |
| Other Expenses | 6838.90 | 5946.50 | 5519.10 | 4792.00 | 4435.30 |
| Total Expenses | 21719.10 | 19713.70 | 19038.50 | 16503.40 | 16308.00 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 7186.30 | 6011.50 | 2991.10 | 2835.50 | 1829.60 |
| | | | | | |
| Profit/Loss Before Tax | 7186.30 | 6011.50 | 2991.10 | 2835.50 | 1829.60 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 1945.90 | 814.40 | 1101.30 | 817.20 | 661.60 |
| Deferred Tax | -322.80 | 726.80 | -222.40 | 114.70 | -801.90 |
| Total Tax Expenses | 1623.10 | 1541.20 | 878.90 | 931.90 | -140.30 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 5563.20 | 4470.30 | 2112.20 | 1903.60 | 1969.90 |
| | | | | | |
| Profit/Loss From Continuing Operations | 5563.20 | 4470.30 | 2112.20 | 1903.60 | 1969.90 |
| | | | | | |
| Profit/Loss For The Period | 5563.20 | 4470.30 | 2112.20 | 1903.60 | 1969.90 |
| Share Of Profit/Loss Of Associates | 14.70 | 37.00 | 70.30 | 48.00 | 56.10 |
| Consolidated Profit/Loss After MI And Associates | 5577.90 | 4507.30 | 2182.50 | 1951.60 | 2026.00 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 335.22 | 271.47 | 131.57 | 117.67 | 122.22 |
| Diluted EPS (Rs.) | 334.59 | 270.90 | 131.21 | 117.34 | 121.99 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 664.80 | 497.90 | 414.60 | 414.70 | 391.60 |
